BLVR

BIOLOGICAL2 trials

Sponsors

Aeris Therapeutics

Conditions

Advanced Upper Lobe Predominant EmphysemaPulmonary Emphysema

Phase 1

US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial Formulation

CompletedNCT00085852

Aeris TherapeuticsPulmonary Emphysema

Start: 2005-04-30End: 2007-06-30Updated: 2008-03-06

Phase 3

Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema

WithdrawnNCT00716053

Aeris TherapeuticsAdvanced Upper Lobe Predominant Emphysema

Start: 2008-12-31End: 2009-12-31Target: 225Updated: 2010-01-18